Experts In The News
![Reuters](/sites/default/files/styles/100_width_25_height/public/news_source/logo/reuters.png?itok=h5i5oG90)
The U.S. FDA on Monday is expected to give its thumbs up or down on Biogen Inc’s aducanumab, a decision that will affect the future of Alzheimer’s disease research and treatment and show the agency’s willingness to approve badly needed medicines based on less than definitive data.
![Headshot of Jeffrey L. Cummings](/sites/default/files/styles/60_width/public/experts/highres/JCummings_headshot_suit.jpg?itok=iQpcDnsz)
![Las Vegas Review Journal](/sites/default/files/styles/100_width_25_height/public/news_source/logo/las-vegas-review-journal.jpg?itok=IX9YBkgU)
A rapidly recovering Las Vegas will be the focus of the global tourism industry Monday, when World of Concrete stages the first major trade show in the United States since the COVID pandemic wiped out the lucrative convention and meeting business.
![Amanda Belarmino Headshot Amanda Belarmino Headshot](/sites/default/files/styles/60_width/public/experts/highres/Hospitality-AmandaBelarmino.jpg?itok=akr-SU0w)
Rush Street Gaming is increasing its hourly salary to $15 for non-tipped workers at Rivers Casinos. The rise comes as many gaming properties nationally apparently face a worker shortage with casinos resuming operations following COVID-19 closings.
![Headshot of Stephen Miller](/sites/default/files/styles/60_width/public/experts/highres/D71422_07.jpg?itok=z9dWM63M)
The National Association of Home Builders has said that lumber prices are triple what they were in April 2020, increasing average single-family home construction by nearly $36,000.
Colgate-Palmolive (Colgate) has sent the first-ever private sector oral care experiment to the International Space Station (ISS), under the sponsorship of the ISS U.S. National Laboratory (National Lab).
![Headshot of Jeffrey Ebersole](/sites/default/files/styles/60_width/public/experts/highres/Ebersole_NC.jpg?itok=Qhrh4Bn4)
![Yahoo!](/sites/default/files/styles/100_width_25_height/public/news_source/logo/yahoo-logo.png?itok=_QObPPuO)
The U.S. FDA on Monday is expected to give its thumbs up or down on Biogen Inc's aducanumab, a decision that will affect the future of Alzheimer's disease research and treatment and show the agency's willingness to approve badly needed medicines based on less than definitive data.
![Headshot of Jeffrey L. Cummings](/sites/default/files/styles/60_width/public/experts/highres/JCummings_headshot_suit.jpg?itok=iQpcDnsz)
The U.S. FDA on Monday is expected to give its thumbs up or down on Biogen Inc's aducanumab, a decision that will affect the future of Alzheimer's disease research and treatment and show the agency's willingness to approve badly needed medicines based on less than definitive data.
![Headshot of Jeffrey L. Cummings](/sites/default/files/styles/60_width/public/experts/highres/JCummings_headshot_suit.jpg?itok=iQpcDnsz)
Opponents say the project would threaten roads, wildlife, and even the night sky itself, not to mention the lifeblood of the South Rim: water. Proponents point to economic development to serve an ever-increasing number of visitors.
![User icon](/sites/default/files/custom-websites/views-no-results/images/user-120x180.jpg)